Blog

  • Mr. Rooter Plumbing of London ON Celebrates 20 Years Serving London and St. Thomas Homeowners

    Marking two decades of service with a 4.8-star rating across more than 2,000 Google reviews, the family-owned London plumber breaks down the basement flooding risks worth checking before the next heavy rain, and the City of London grant that covers up to 90 percent of the fix.

    Marking two decades of service with a 4.8-star rating across more than 2,000 Google reviews, the family-owned London plumber breaks down the basement flooding risks worth checking before the next heavy rain, and the City of London grant that covers up to 90 percent of the fix.

    Originally published via Source Article.

  • Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil

    MONTREAL, Aug. 27, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). The supplemental application for the additional indication was selected for review under Project Orbis.

    Originally published via Source Article.

  • Thérapeutique Knight annonce le dépôt d'une soumission réglementaire supplémentaire pour MINJUVI® (tafasitamab) au Brésil

    MONTRÉAL, 27 août 2026 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (« Knight ») (TSX : GUD), société pharmaceutique panaméricaine (hors États-Unis), a annoncé aujourd’hui avoir déposé une demande supplémentaire auprès de l’ANVISA, l’agence brésilienne de réglementation de la santé, en vue d’obtenir l’autorisation d’une indication supplémentaire pour MINJUVI® (tafasitamab), en association avec le lénalidomide ajouté au R-CHOP (rituximab, cyclophosphamide, doxorubicine, vincristine et prednisone; Tafa-Len-R-CHOP), à titre de traitement de première intention chez les adultes atteints d’un lymphome diffus à grandes cellules B (DLBCL) ou d’un lymphome à cellules B de haut grade (HGBL) n’ayant reçu aucun traitement antérieur. La demande supplémentaire visant cette nouvelle indication a été sélectionnée pour un examen dans le cadre du Project Orbis.

    Originally published via Source Article.

  • Prime Drink Group Provides Bi-Weekly MCTO Status Report

    MONTREAL, Aug. 27, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30 and August 14, 2026, the Company voluntarily applied for and the Company’s principal regulator, the British Columbia Securities Commission (the “BCSC”) granted a management cease trade order (the “MCTO”) dated July 30, 2026, under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”) and provided the Company with an extension to file its annual financial statements for the year ended March 31, 2026, including the related management’s discussion and analysis, and Chief Executive Officer and Chief Financial certifications on or before July 29, 2026 (collectively the “Annual Financial Filings”). The deadline has been extended to on or before September 28, 2026.

    Originally published via Source Article.

  • Groupe Prime Drink fournit un rapport bihebdomadaire sur le statut du MCTO

    MONTRÉAL, 27 août 2026 (GLOBE NEWSWIRE) — Groupe Prime Drink Corp. (CSE : PRME) (« Prime » ou la « Société ») annonce que, conformément à ses communiqués de presse du 30 juillet et du 14 août 2026, la Société a volontairement déposé une demande auprès de son autorité principale, la British Columbia Securities Commission (« BCSC »), qui a accordé un ordre d’interdiction d’opérations aux dirigeants (« MCTO ») daté du 30 juillet 2026, en vertu de la Politique nationale 12-203 — Ordres d’interdiction d’opérations aux dirigeants (« NP 12-203 »), et a accordé à la Société un délai supplémentaire pour déposer ses états financiers annuels pour la période terminée le 31 mars 2026, y compris le rapport de gestion et les attestations connexes du chef de la direction et du chef de la direction financière, au plus tard le 29 juillet 2026 (collectivement, les « Déclarations financières annuelles »). Ce délai a été prolongé jusqu’au 28 septembre 2026 inclusivement.

    Originally published via Source Article.

  • The Grid's Biggest Problem Isn't Making Power. It's Getting It to the Right Place at the Right Time

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    Originally published via Source Article.

  • The Grid's Biggest Problem Isn't Making Power. It's Getting It to the Right Place at the Right Time

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    Originally published via Source Article.

  • The Grid's Biggest Problem Isn't Making Power. It's Getting It to the Right Place at the Right Time

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    Originally published via Source Article.

  • The Grid's Biggest Problem Isn't Making Power. It's Getting It to the Right Place at the Right Time

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    Originally published via Source Article.

  • The Grid's Biggest Problem Isn't Making Power. It's Getting It to the Right Place at the Right Time

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    News Provided by Equity Insider on behalf of NOMAD Power Solutions, Inc.

    Originally published via Source Article.